Clinical Services

The surgical landscape is continuously evolving which is impacting patient care and stakeholder revenues across the industry. As inpatient surgical volumes and case mixes stagnate or decrease, provider competition for profitable surgical volumes is increasing rapidly. And with these changes come new expectations and implications for providers, payers, and industry leaders. Thriving in this evolving landscape requires an understanding of not only what’s happening now, but also what the future of surgery looks like.

Liquid biopsies detect tumor biomarkers in blood and other bodily fluids instead of in solid tissue samples. While liquid biopsies are already being used to match cancer patients to appropriate targeted therapies, new tests entering the market can be used for cancer detection and real-time disease monitoring.

The year 2020 held the promise of a blank slate for health care leaders, but by early March, that promise dissipated due to the global pandemic and concurrent economic recession. Read our executive briefing to learn about the four major trends impacting CV service lines in 2021 and the takeaways for each.

Increasing cancer screening has been a long-time goal for oncology leaders. However, achieving this goal has become even more important – and challenging – as oncology leaders aim to mitigate the impact of the delayed cancer screenings that have resulted from the Covid-19 pandemic. Use the resources below to help you build a cancer screening program, grow cancer screening volumes, and stay up to date on cancer screening guidelines and recommendations.

Learn how Virtua Health and The Bone and Joint Institute of Tennessee (BJIT) avoided leaking joint replacements to competitor ambulatory surgery centers (ASCs) by proactively establishing their own hospital-physician ASC joint ventures.